Hepatitis B Virus
Artemisinin/artesunate inhibits hepatitis B virus production
Published in Hepatitis Weekly, January 16th, 2006
"The antiviral effect against HBV of artemisinin, its derivative artesunate and other compounds highly purified from traditional Chinese medicine remedies, were investigated. HBV production by permanently transfected HepG2 2.2.15 cells was determined by measuring the release of surface protein (HBsAg) and HBV-DNA after drug exposure (0.01-100 mcM) for 21 days."
"The forms of HBV-DNA released were investigated by Southern-blotting. Neutral Red retention test was used to evaluate drug-induced toxicity on host cells,"...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (2006-01-16)
More Articles from Hepatitis Weekly
- Chronic Hepatitis C
Iron accumulation in chronic hepatitis C is influenced by mutations in HFE - Hepatitis C Virus
HCV core protein inhibits promyelocytic leukemia function in hepatoma cells - Hepatitis C Virus
Hepatitis C virus nonstructural proteins inhibit apolipoprotein B100 secretion - Hepatitis E Virus
An immunochromatographic assay is sensitive and specific for hepatitis E virus - Adverse Drug Reaction
Antiretroviral toxicity may increase death rate from liver-related disease - Business Update
Biopharma company updates European commercialization strategy to reduce expenses - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
